Item 7.01 of this Form 8-K and the press release furnished
as
Exhibit 99.1 to this Form 8-K shall not be deemed “filed” for purposes of
Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or
otherwise subject to the liabilities of that section, nor shall it be deemed
incorporated by reference in any filing under the Securities Act of 1933,
as
amended, or the Exchange Act, except as expressly set forth by specific
reference in such a filing.
(d) Exhibits
|
Exhibit No.
|
|
Description
|
|
99.1
|
Press
Release of Laboratory Corporation of America® Holdings and Vanda
Pharmaceuticals Inc. dated June 5,
2008.
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant
has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
|
VANDA
PHARMACEUTICALS INC.
|
||
|
|
|
|
|
|
By:
|
/s/
STEVEN
A. SHALLCROSS
|
|
|
|
Name:
Steven A. Shallcross
|
|
|
|
Title:
Senior Vice President, Chief Financial
Officer
and Treasurer
|
Dated:
June 5, 2008